- Home
- AM vs JAZZ Comparison
AM vs JAZZ Comparison
Compare AM & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AM
- JAZZ
- Stock Information
- Founded
- AM 2013
- JAZZ 2003
- Country
- AM United States
- JAZZ Ireland
- Employees
- AM N/A
- JAZZ N/A
- Industry
- AM Natural Gas Distribution
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- AM Utilities
- JAZZ Health Care
- Exchange
- AM Nasdaq
- JAZZ Nasdaq
- Market Cap
- AM 8.9B
- JAZZ 7.3B
- IPO Year
- AM 2014
- JAZZ 2007
- Fundamental
- Price
- AM $18.95
- JAZZ $108.07
- Analyst Decision
- AM Hold
- JAZZ Strong Buy
- Analyst Count
- AM 2
- JAZZ 13
- Target Price
- AM $16.50
- JAZZ $181.85
- AVG Volume (30 Days)
- AM 2.4M
- JAZZ 1.3M
- Earning Date
- AM 04-30-2025
- JAZZ 05-06-2025
- Dividend Yield
- AM 4.79%
- JAZZ N/A
- EPS Growth
- AM 8.49
- JAZZ 49.21
- EPS
- AM 0.87
- JAZZ 7.51
- Revenue
- AM $1,188,943,000.00
- JAZZ $4,064,808,000.00
- Revenue This Year
- AM $0.69
- JAZZ $5.92
- Revenue Next Year
- AM $2.45
- JAZZ $4.22
- P/E Ratio
- AM $21.64
- JAZZ $14.39
- Revenue Growth
- AM 5.03
- JAZZ 5.76
- 52 Week Low
- AM $13.12
- JAZZ $95.49
- 52 Week High
- AM $19.06
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- AM 62.35
- JAZZ 47.97
- Support Level
- AM $18.55
- JAZZ $106.69
- Resistance Level
- AM $19.06
- JAZZ $110.48
- Average True Range (ATR)
- AM 0.31
- JAZZ 3.56
- MACD
- AM -0.01
- JAZZ 0.55
- Stochastic Oscillator
- AM 69.39
- JAZZ 68.77
About AM Antero Midstream Corporation
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin located in West Virginia and Ohio. The company has two operating segments; the Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio and the Water Handling segment includes two independent systems that deliver water from sources including the Ohio River, local reservoirs and several regional waterways. It derives a majority of its revenue from the Gathering and Processing segment.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.